Skip to main content

William Hughes Comment On Regulatory Notice 22-08

Regarding Pro-Shares (SDS), "we the people" do not want more regulation on "complex products" or any other regulation that prevents free will based on market conditions. Instead, your energy should be focused on the education of risk for these products ONLY. Your intervention in this matter, in itself, is controlling and disruptive to current investors. An attempt to control this sector will, in itself, cause an exit of cash flow leading to manipulation.

Beverly Rice Comment On Regulatory Notice 22-08

Please do Not limit me or my financial investment adviser by limiting the use of leveraged products. Granted these are aggressive products, but everything about stock buying or stock shorting, is aggressive. These products are simply tools to be used at the appropriate time. For example, during big market corrections in the past they give you a chance to recover more quickly from a 20% plus stock market decline, in the NASDAQ, or the S&P 500, etc. I do not use or want the short products in my account, and my investment adviser understands that.

Ge Bai Comment On Regulatory Notice 22-08

May 9, 2022 Jennifer Piorko Mitchell, JD, MBA Office of the Corporate Secretary FINRA 1735 K Street, NW Washington, DC 20006 Re: FINRA Regulatory Notice 22-08 Dear Ms. Mitchell: Thank you for giving the public an opportunity to comment on the Regulatory Notice 22-08. I am a professor of accounting at the Johns Hopkins Carey Business School. I oppose the rules proposed in Notice 22-08. These rules, with the intention to protect investors, will limit investor access to publicly offered complex ETFs and harm investors’ best interests.